Kairos Pharma KAPA
NYSE KAPA
$0.49 -0.01 (-3.01%)
As of: Nov 10, 2026 · 3:53 PM EST

Kairos Pharma (KAPA) EBIT (2023 - 2025)

Updated

Kairos Pharma's EBIT came in at -$5.57 million for FY2025, compared with -$2.34 million in FY2024.

Analysis

Kairos Pharma (KAPA) EBIT (2023 - 2025) Analysis & Trends

  • Per Business Quant, earlier years put EBIT at -$2.34 million in FY2024 and -$1.71 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 12.79 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 6.18 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 6.27 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 5.59 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 3.16 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 3.71 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 3.46 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 5.47 Bn
10 Kairos Pharma 9.22 Mn -3.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -1.46 Mn
Mar 31, 2025 -1.27 Mn
Dec 31, 2024 -1.45 Mn
Sep 30, 2024 -383,000.00
Jun 30, 2024 -222,000.00
Mar 31, 2024 -287,000.00
Dec 31, 2023 -1.09 Mn
Sep 30, 2023 -287,000.00
API Access

Kairos Pharma EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=KAPA&period=max&api_key=YOUR_API_KEY